BR9807368A - Comprimidos de oxacarvazepina revestidos com pelìcula - Google Patents
Comprimidos de oxacarvazepina revestidos com pelìculaInfo
- Publication number
- BR9807368A BR9807368A BR9807368-0A BR9807368A BR9807368A BR 9807368 A BR9807368 A BR 9807368A BR 9807368 A BR9807368 A BR 9807368A BR 9807368 A BR9807368 A BR 9807368A
- Authority
- BR
- Brazil
- Prior art keywords
- film
- tablets
- coated
- oxacarbazepine
- oxacarvazepine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
- C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
Abstract
Patente de Invenção:<B>" COMPRIMIDOS DE OXACARBAZEPINA REVESTIDOS COM PELìCULA"<D>. A invenção refere-se a formulações, por exemplo comprimidos revestidos com película, contendo oxacarbazepina e a processos para a produção das referidas do formulações. Os comprimidos revestidos com película têm um núcleo de comprimido compreendendo uma dose terapeuticamente eficaz de oxacarbazepina em uma forma finamente triturada tendo um tamanho de partícula médio de 4 a 12 <109>m (valor médio), e um revestimento externo permeável hidrófilo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH33197 | 1997-02-14 | ||
PCT/EP1998/000794 WO1998035681A1 (en) | 1997-02-14 | 1998-02-12 | Oxacarbazepine film-coated tablets |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9807368A true BR9807368A (pt) | 2000-03-14 |
Family
ID=4184588
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9807368-0A BR9807368A (pt) | 1997-02-14 | 1998-02-12 | Comprimidos de oxacarvazepina revestidos com pelìcula |
Country Status (32)
Country | Link |
---|---|
US (2) | US20070036863A1 (pt) |
EP (1) | EP0966287B1 (pt) |
JP (3) | JP2000511935A (pt) |
KR (3) | KR19980071337A (pt) |
CN (2) | CN1170542C (pt) |
AR (1) | AR011142A1 (pt) |
AT (1) | ATE239481T1 (pt) |
AU (1) | AU738030B2 (pt) |
BR (1) | BR9807368A (pt) |
CA (1) | CA2277791C (pt) |
CO (1) | CO4920215A1 (pt) |
CY (1) | CY2480B1 (pt) |
CZ (1) | CZ298840B6 (pt) |
DE (1) | DE69814367T2 (pt) |
DK (1) | DK0966287T3 (pt) |
ES (1) | ES2199422T3 (pt) |
HK (1) | HK1024423A1 (pt) |
HU (1) | HU227807B1 (pt) |
ID (1) | ID22348A (pt) |
MY (1) | MY117582A (pt) |
NO (1) | NO327486B1 (pt) |
NZ (1) | NZ336946A (pt) |
PE (1) | PE58999A1 (pt) |
PL (1) | PL193332B1 (pt) |
PT (1) | PT966287E (pt) |
RU (1) | RU2201218C2 (pt) |
SK (1) | SK284503B6 (pt) |
TR (1) | TR199901804T2 (pt) |
TW (1) | TW529957B (pt) |
UY (1) | UY24888A1 (pt) |
WO (1) | WO1998035681A1 (pt) |
ZA (1) | ZA981205B (pt) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CO4920215A1 (es) * | 1997-02-14 | 2000-05-29 | Novartis Ag | Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones |
GB9925962D0 (en) * | 1999-11-02 | 1999-12-29 | Novartis Ag | Organic compounds |
US6368628B1 (en) * | 2000-05-26 | 2002-04-09 | Pharma Pass Llc | Sustained release pharmaceutical composition free of food effect |
CA2469246A1 (en) | 2001-12-21 | 2003-07-03 | Pfizer Products Inc. | Directly compressible formulations of azithromycin |
GB0221956D0 (en) * | 2002-09-20 | 2002-10-30 | Novartis Ag | Organic compounds |
EP1663247B1 (en) | 2003-09-03 | 2009-10-28 | Novartis AG | Use of oxcarbazepine for the improvement of sleep in patients suffering from chronic pain |
AR048318A1 (es) * | 2004-03-22 | 2006-04-19 | Novartis Ag | Formulaciones de matriz orales que comprenden licarbazepina |
PE20060124A1 (es) * | 2004-03-22 | 2006-03-07 | Novartis Ag | Tabletas de desintegracion que comprenden licarbazepina |
US8367105B2 (en) | 2004-11-10 | 2013-02-05 | Teva Pharmaceutical Industries, Ltd. | Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby |
US20060252745A1 (en) | 2005-05-06 | 2006-11-09 | Almeida Jose L D | Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use |
MY143784A (en) | 2005-09-23 | 2011-07-15 | Hoffmann La Roche | Novel dosage formulation |
HUE032640T2 (en) | 2005-11-08 | 2017-10-30 | Vertex Pharma | Heterocyclic modulator of ATP-binding cassette transcripts |
CA2628716C (en) * | 2005-11-10 | 2016-09-27 | Alphapharm Pty Ltd | Process to control particle size |
AU2006313009B2 (en) * | 2005-11-10 | 2013-10-24 | Alphapharm Pty Ltd | Process to control particle size |
JP2008540346A (ja) * | 2006-01-31 | 2008-11-20 | テバ ファーマシューティカル インダストリーズ リミティド | オキシカルバゼピンの医薬製剤及びその調製方法 |
EP1815849A1 (en) * | 2006-01-31 | 2007-08-08 | Teva Pharmaceutical Industries Ltd | Oxcarbazepine pharmaceutical formulation and its method of preparation, wherein oxcarbazepine has a broad and multi-modal particle size distribution |
AU2007242062A1 (en) * | 2006-04-21 | 2007-11-01 | Alphapharm Pty Ltd | Pharmaceutical compositions of oxcarbazepine with a median particle size of 15 to 30 microns |
EP2018157A2 (en) | 2006-04-26 | 2009-01-28 | Astron Research Limited | Controlled release formulation comprising anti-epileptic drugs |
EP2359830B1 (en) * | 2006-04-26 | 2012-09-19 | Supernus Pharmaceuticals, Inc. | Controlled released preparations of oxcarbazepine having sigmoidal release profile |
US20080138403A1 (en) * | 2006-12-08 | 2008-06-12 | Sun Pharmaceutical Industries Ltd. | Pharmaceutical dosage forms of oxcarbazepine |
JP2010513324A (ja) | 2006-12-21 | 2010-04-30 | アルファファーム ピーティーワイ リミテッド | 医薬化合物および医薬組成物 |
GB0700773D0 (en) | 2007-01-15 | 2007-02-21 | Portela & Ca Sa | Drug therapies |
EP1970056A1 (en) * | 2007-03-15 | 2008-09-17 | Polichem S.A. | Time-specific delayed/pulsatile release dosage forms |
WO2008141751A2 (en) * | 2007-05-23 | 2008-11-27 | Ratiopharm Gmbh | Pharmaceutical compositions comprising oxcarbazepine |
US8372431B2 (en) | 2007-10-26 | 2013-02-12 | Bial-Portela & C.A., S.A. | Pharmaceutical composition comprising licarbazepine acetate |
US8507534B2 (en) | 2007-12-07 | 2013-08-13 | Vertex Pharmaceuticals Incorporated | Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
JP2013523833A (ja) | 2010-04-07 | 2013-06-17 | バーテックス ファーマシューティカルズ インコーポレイテッド | 3−(6−(1−(2,2−ジフルオロベンゾ[d][1,3]ジオキソール−5−イル)シクロプロパンカルボキサミド)−3−メチルピリジン−2−イル)安息香酸の医薬組成物およびその投与 |
WO2015073231A1 (en) | 2013-11-12 | 2015-05-21 | Vertex Pharmaceuticals Incorporated | Process of preparing pharmaceutical compositions for the treatment of cftr mediated diseases |
CN103735527B (zh) * | 2013-12-24 | 2014-09-10 | 武汉人福药业有限责任公司 | 一种奥卡西平片剂及其制备方法 |
WO2018208242A1 (en) | 2017-05-10 | 2018-11-15 | İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi | Formulation of deferasirox tablet for oral suspension composition with better processability |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI75561C (fi) * | 1979-10-30 | 1988-07-11 | Ciba Geigy Ag | Foerfarande foer framstaellning av 5- karbamoyl-10-oxo-10,11-dihydro-5h-dibens/b,f/azepin och daertill noedvaendiga mellanprodukter. |
CH649080A5 (de) * | 1981-04-16 | 1985-04-30 | Ciba Geigy Ag | 5h-dibenz(b,f)azepin-5-carboxamide als mittel zur prophylaxe und behandlung von zerebraler leistungsinsuffizienz. |
US4609675A (en) * | 1984-08-17 | 1986-09-02 | The Upjohn Company | Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing |
JPS6257467A (ja) * | 1985-09-06 | 1987-03-13 | Asahi Glass Co Ltd | コ−テイング剤組成物 |
GB8524001D0 (en) * | 1985-09-30 | 1985-11-06 | Glaxo Group Ltd | Pharmaceutical composition |
CH668187A5 (de) * | 1986-08-07 | 1988-12-15 | Ciba Geigy Ag | Therapeutisches system mit systemischer wirkung. |
DD295760A5 (de) * | 1989-01-31 | 1991-11-14 | Martin-Luther-Universitaet Halle Wittenberg,De | Arzneistoffreigabesystem mit kotrollierter wirkstoffreisetzung |
US5145684A (en) * | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
US5231089A (en) * | 1991-12-02 | 1993-07-27 | University Of Florida | Method of improving oral bioavailability of carbamazepine |
FR2699077B1 (fr) * | 1992-12-16 | 1995-01-13 | Rhone Poulenc Rorer Sa | Application d'anticonvulsivants dans le traitement de lésions neurologiques liées à des traumatismes. |
FR2702148B1 (fr) * | 1993-03-05 | 1995-04-07 | Rhone Poulenc Rorer Sa | Application d'anticonvulsivants dans le traitement du neuro-sida. |
US5472714A (en) * | 1993-09-08 | 1995-12-05 | Ciba-Geigy Corporation | Double-layered oxcarbazepine tablets |
ZA953078B (en) * | 1994-04-28 | 1996-01-05 | Alza Corp | Effective therapy for epilepsies |
US5478654A (en) * | 1994-05-06 | 1995-12-26 | Gencorp Inc. | Solventless carboxylated butadiene-vinylidene chloride adhesives for bonding rubber to metal |
US6296873B1 (en) * | 1997-01-23 | 2001-10-02 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Zero-order sustained release delivery system for carbamazephine derivatives |
US5980942A (en) * | 1997-01-23 | 1999-11-09 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Zero-order sustained release matrix tablet formulations of carbamazepine |
CO4920215A1 (es) * | 1997-02-14 | 2000-05-29 | Novartis Ag | Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones |
-
1998
- 1998-02-05 CO CO98005805A patent/CO4920215A1/es unknown
- 1998-02-09 MY MYPI98000504A patent/MY117582A/en unknown
- 1998-02-11 PE PE1998000100A patent/PE58999A1/es not_active Application Discontinuation
- 1998-02-12 PT PT98908091T patent/PT966287E/pt unknown
- 1998-02-12 TR TR1999/01804T patent/TR199901804T2/xx unknown
- 1998-02-12 ES ES98908091T patent/ES2199422T3/es not_active Expired - Lifetime
- 1998-02-12 DK DK98908091T patent/DK0966287T3/da active
- 1998-02-12 HU HU0000886A patent/HU227807B1/hu not_active IP Right Cessation
- 1998-02-12 DE DE69814367T patent/DE69814367T2/de not_active Revoked
- 1998-02-12 JP JP10535347A patent/JP2000511935A/ja not_active Withdrawn
- 1998-02-12 CN CNB988024977A patent/CN1170542C/zh not_active Expired - Fee Related
- 1998-02-12 AU AU66222/98A patent/AU738030B2/en not_active Ceased
- 1998-02-12 CA CA002277791A patent/CA2277791C/en not_active Expired - Fee Related
- 1998-02-12 CZ CZ0287999A patent/CZ298840B6/cs not_active IP Right Cessation
- 1998-02-12 AR ARP980100639A patent/AR011142A1/es not_active Application Discontinuation
- 1998-02-12 NZ NZ336946A patent/NZ336946A/en not_active IP Right Cessation
- 1998-02-12 CN CNA200410075200XA patent/CN1626093A/zh active Pending
- 1998-02-12 RU RU99119599/14A patent/RU2201218C2/ru not_active IP Right Cessation
- 1998-02-12 SK SK1098-99A patent/SK284503B6/sk not_active IP Right Cessation
- 1998-02-12 BR BR9807368-0A patent/BR9807368A/pt not_active Application Discontinuation
- 1998-02-12 EP EP98908091A patent/EP0966287B1/en not_active Revoked
- 1998-02-12 PL PL334959A patent/PL193332B1/pl unknown
- 1998-02-12 AT AT98908091T patent/ATE239481T1/de not_active IP Right Cessation
- 1998-02-12 ID IDW990810A patent/ID22348A/id unknown
- 1998-02-12 WO PCT/EP1998/000794 patent/WO1998035681A1/en active IP Right Grant
- 1998-02-13 KR KR1019980004327A patent/KR19980071337A/ko not_active Application Discontinuation
- 1998-02-13 ZA ZA981205A patent/ZA981205B/xx unknown
- 1998-02-13 UY UY24888A patent/UY24888A1/es not_active IP Right Cessation
- 1998-02-23 TW TW087102046A patent/TW529957B/zh not_active IP Right Cessation
-
1999
- 1999-08-13 NO NO19993919A patent/NO327486B1/no not_active IP Right Cessation
-
2000
- 2000-06-28 HK HK00103912A patent/HK1024423A1/xx not_active IP Right Cessation
-
2004
- 2004-10-07 CY CY0400074A patent/CY2480B1/xx unknown
-
2005
- 2005-11-30 JP JP2005346338A patent/JP2006077029A/ja not_active Withdrawn
-
2006
- 2006-10-18 US US11/582,802 patent/US20070036863A1/en not_active Abandoned
-
2007
- 2007-07-17 US US11/879,329 patent/US20080014269A1/en not_active Abandoned
-
2009
- 2009-03-20 KR KR1020090024168A patent/KR20090037873A/ko not_active Application Discontinuation
-
2010
- 2010-02-26 JP JP2010041778A patent/JP2010132694A/ja active Pending
-
2012
- 2012-06-18 KR KR1020120065092A patent/KR20120079826A/ko not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9807368A (pt) | Comprimidos de oxacarvazepina revestidos com pelìcula | |
CA2315261A1 (en) | Oral pharmaceutical extended release dosage form | |
CA2220506A1 (en) | Powder coating composition for electrostatic coating of pharmaceutical substrates | |
CA2186039A1 (en) | New oral pharmaceutical dosage form | |
WO1999059544A3 (en) | Orally disintegrable tablets | |
HUP9900028A3 (en) | Pharmaceutically active quinazoline compounds, their production, use thereof and medicament containing them | |
AU5680100A (en) | Controlled release and taste masking oral pharmaceutical compositions | |
EP0259219A3 (en) | Controlled release tablet | |
AU646399B2 (en) | Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets | |
IL142474A0 (en) | Pharmaceutical formulation comprising omeprazole | |
AU4121297A (en) | Galenic form with extended release of milnacipran | |
CA2136411A1 (en) | Immediate Release Tablet Cores of Insoluble Drugs Having Sustained Release Coating | |
CA2329172A1 (en) | Storage stable extended release oral dosage composition comprising desloratadine and pseudoephedrine | |
CA2179540A1 (en) | Accelerated release composition containing bromocriptine | |
AU691105B2 (en) | Use of retinoids in a cosmetic composition or for the manufacture of a pharmaceutical composition | |
ATE235232T1 (de) | Lutschtablette zur modifizierten freisetzung von wirkstoffen im gastrointestinaltrakt | |
AU5861499A (en) | Agitation-independent pharmaceutical multiple unit retard preparations and method for the production thereof | |
AU4519399A (en) | Anti-inflammatory pharmaceutical formulations | |
GB2316086A (en) | Powder coating composition for electrostatic coating of pharmaceutical substrates | |
AU6367496A (en) | New hormonal medicaments and their use for the correction of oestrogenic deficiencies | |
AU5655696A (en) | Pharmaceutical composition containing acetylcysteine, carboc ysteine or erdosteine in combination with a beta 2 agonist a nd an expectorant for the treatment of respiratory tract dis orders | |
AU3598299A (en) | Improved compositions for inhalation | |
HUP9800512A3 (en) | Salts of bismuthum and antibiotica of the moenomycin group, process for producing them, their use and pharmaceutical compositions containing them | |
BR9508202A (pt) | Forma medicinal de carbamazepina com liberação de substáncia atíva retardada | |
ECSP982406A (es) | Tabletas de oxacarbazepina recubiertas de pelicula |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B65X | Notification of requirement for priority examination of patent application | ||
B65Y | Grant of priority examination of the patent application (request complies with dec. 132/06 of 20061117) | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B11Z | Dismissal: petition dismissal - article 216, par 2 of industrial property law |
Free format text: REFERENCIA: PETICAO INPI/RJ 020070058870 DE 08.05.2007, DE ACORDO COM O ART. 216 2O DA LPI. |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFERIMENTO DO PRESENTE PEDIDO, UMA VEZ QUE NAO ATENDE AO REQUISITO DE ATIVIDADE INVENTIVA ( ART. 8O COMBINADO COM ART. 13 DA LPI ) NAO APRESENTA SUFICIENCIA DESCRITIVA ( ART. 24 DA LPI ) |
|
B12B | Appeal against refusal [chapter 12.2 patent gazette] |